Like it or not, the COVID-19 pandemic with its veiled threat of forced vaccinations, contact tracing, and genetically encoded vaccines is propelling humanity at warp speed into a whole new frontier—a surveillance matrix—the likes of which we’ve only previously encountered in science fiction.
Those who eye these developments with lingering mistrust have good reason to be leery: the government has long had a tendency to unleash untold horrors upon the world in the name of global conquest, the acquisition of greater wealth, scientific experimentation, and technological advances, all packaged in the guise of the greater good.
Now this same government—which has taken every bit of technology sold to us as being in our best interests (GPS devices, surveillance, nonlethal weapons, etc.) and used it against us, to track, control and trap us—wants us to fall in line as it prepares to roll out COVID-19 vaccines that owe a great debt to the Pentagon’s Defense Advanced Research Projects Agency for its past work on how to weaponize and defend against infectious diseases.
This is all part of Operation Warp Speed, which President Trump has likened to the Manhattan Project, a covert government effort spearheaded by the military to engineer and build the world’s first atomic bomb.
There is every reason to tread cautiously.
There is a sinister world beyond that which we perceive, one in which power players jockey for control over the one commodity that is a necessary ingredient for total domination: you.
By you, I mean you the individual in all your singular humanness.
Remaining singularly human and retaining your individuality and dominion over yourself—mind, body and soul—in the face of corporate and government technologies that aim to invade, intrude, monitor, manipulate and control us may be one of the greatest challenges before us.
The groundwork being laid with these vaccines is a prologue to what will become the police state’s conquest of a new, relatively uncharted, frontier: inner space, specifically, the inner workings (genetic, biological, biometric, mental, emotional) of the human race.
The term “matrix” was introduced into our cultural lexicon by the 1999 film The Matrix in which Neo, a computer programmer/hacker, awakens to the reality that humans have been enslaved by artificial intelligence and are being harvested for their bio-electrical energy.
Hardwired to a neuro-interactive simulation of reality called the “Matrix,” humans are kept inactive and docile while robotic androids gather the electricity their bodies generate. In order for the machines who run the Matrix to maintain control, they impose what appears to be a perfect world for humans to keep them distracted, content, and submissive.
Here’s the thing: Neo’s Matrix is not so far removed from our own technologically-hardwired worlds in which we’re increasingly beholden to corporate giants such as Google for powering so much of our lives. As journalist Ben Thompson explains:
Everything we do is increasingly dependent on and, ultimately, controlled by our internet-connected, electronic devices. For example, in 2007, there were an estimated 10 million sensor devices connecting human utilized electronic devices (cell phones, laptops, etc.) to the Internet. By 2013, it had increased to 3.5 billion. By 2030, it is estimated to reach 100 trillion.
Much, if not all, of our electronic devices will be connected to Google, a neural network that approximates a massive global brain.
Google’s resources, beyond anything the world has ever seen, includes the huge data sets that result from one billion people using Google every single day and the Google knowledge graph “which consists of 800 million concepts and billions of relationships between them.”
The end goal? The creation of a new “human” species, so to speak, and the NSA, the Pentagon and the “Matrix” of surveillance agencies are part of the plan. As William Binney, one of the highest-level whistleblowers to ever emerge from the NSA, said, “The ultimate goal of the NSA is total population control.”
Mind you, this isn’t population control in the classic sense. It’s more about controlling the population through singularity, a marriage of sorts between machine and human beings in which artificial intelligence and the human brain will merge to form a superhuman mind.
The term “singularity”—that is, computers simulating human life itself—was coined years ago by mathematical geniuses Stanislaw Ulam and John von Neumann. “The ever accelerating progress of technology,” warned von Neumann, “gives the appearance of approaching some essential singularity in the history of the race beyond which human affairs, as we know them, could not continue.”
Advances in neuroscience indicate that future behavior can be predicted based upon activity in certain portions of the brain, potentially creating a nightmare scenario in which government officials select certain segments of the population for more invasive surveillance or quarantine based solely upon their brain chemistry.
Case in point: researchers at the Mind Research Center scanned the brains of thousands of prison inmates in order to track their brain chemistry and their behavior after release. In one experiment, researchers determined that inmates with lower levels of activity in the area of the brain associated with error processing allegedly had a higher likelihood of committing a crime within four years of being released from prison. While researchers have cautioned against using the results of their research as a method of predicting future crime, it will undoubtedly become a focus of study for government officials.
There’s no limit to what can be accomplished—for good or ill—using brain-computer interfaces.
Researchers at Duke University Medical Center have created a brain-to-brain interface between lab rats, which allows them to transfer information directly between brains. In one particular experiment, researchers trained a rat to perform a task where it would hit a lever when lit. The trained rat then had its brain connected to an untrained rat’s brain via electrodes. The untrained rat was then able to learn the trained rat’s behavior via electrical stimulation. This even worked over great distances using the Internet, with a lab rat in North Carolina guiding the actions of a lab rat in Brazil.
Clearly, we are rapidly moving into the “posthuman era,” one in which humans will become a new type of being. “Technological devices,” writes journalist Marcelo Gleiser, “will be implanted in our heads and bodies, or used peripherally, like Google Glass, extending our senses and cognitive abilities.”
Transhumanism—the fusing of machines and people—is here to stay and will continue to grow.
In fact, as science and technology continue to advance, the ability to control humans will only increase. In 2014, for example, it was revealed that scientists have discovered how to deactivate that part of our brains that controls whether we are conscious or not. When researchers at George Washington University sent high frequency electrical signals to the claustrum—that thin sheet of neurons running between the left and right sides of the brain—their patients lost consciousness. Indeed, one patient started speaking more slowly until she became silent and still. When she regained consciousness, she had no memory of the event.
Add to this the fact that increasingly humans will be implanted with microchips for such benign purposes as tracking children or as medical devices to assist with our health. Such devices “point to an uber-surveillance society that is Big Brother on the inside looking out,” warns Dr. Katina Michael. “Governments or large corporations would have the ability to track people’s actions and movements, categorize them into different socio-economic, political, racial, or consumer groups and ultimately even control them.”
All of this indicates a new path forward for large corporations and government entities that want to achieve absolute social control. Instead of relying solely on marauding SWAT teams and full-fledged surveillance apparatuses, they will work to manipulate our emotions to keep us in lock step with the American police state.
Now add this warp speed-deployed vaccine to that mix, with all of the associated unknown and fearsome possibilities for altering or controlling human epigenetics, and you start to see the perils inherent in blindly adopting emerging technologies without any restrictions in place to guard against technological tyranny and abuse.
It’s one thing for the starship Enterprise to boldly go where no man has gone before, but even Mr. Spock recognized the dangers of a world dominated by AI. “Computers make excellent and efficient servants,” he observed in “The Ultimate Computer” episode of Star Trek, “but I have no wish to serve under them.”
The vaccine is here and about to be rolled out. Why then is the testing being pushed so hard? Is there more to these tests than meets the eye? In the end we know this is about control, the complete enslavement of the human race by the few who control it all. Let's see what they have for us.
YES, THEY CAN VACCINATE US THROUGH NASAL TEST SWABS AND TARGET THE BRAIN
I don’t know if they do it, because no independent researchers examine those swabs, but I have always pointed out that our overlords seem more concerned with testing than with vaccinating. Almost like the vaccines were the bait and tests were the switch. And now we also know they totally CAN do that.
Just follow the science below.
November 3, 2020
RESEARCHERS ENGINEER TINY MACHINES THAT DELIVER MEDICINE EFFICIENTLY
Inspired by a parasitic worm that digs its sharp teeth into its host’s intestines, Johns Hopkins researchers have designed tiny, star-shaped microdevices that can latch onto intestinal mucosa and release drugs into the body.
David Gracias, Ph.D., a professor in the Johns Hopkins University Whiting School of Engineering, and Johns Hopkins gastroenterologist Florin M. Selaru, M.D., director of the Johns Hopkins Inflammatory Bowel Disease Center, led a team of researchers and biomedical engineers that designed and tested shape-changing microdevices that mimic the way the parasitic hookworm affixes itself to an organism’s intestines.
Made of metal and thin, shape-changing film and coated in a heat-sensitive paraffin wax, “theragrippers,” each roughly the size of a dust speck, potentially can carry any drug and release it gradually into the body.
The team published results of an animal study this week as the cover article in the journal Science Advances.
Gradual or extended release of a drug is a long-sought goal in medicine. Selaru explains that a problem with extended-release drugs is they often make their way entirely through the gastrointestinal tract before they’ve finished dispensing their medication.
“Normal constriction and relaxation of GI tract muscles make it impossible for extended-release drugs to stay in the intestine long enough for the patient to receive the full dose,” says Selaru, who has collaborated with Gracias for more than 10 years. “We’ve been working to solve this problem by designing these small drug carriers that can autonomously latch onto the intestinal mucosa and keep the drug load inside the GI tract for a desired duration of time.”
Thousands of theragrippers can be deployed in the GI tract. When the paraffin wax coating on the grippers reaches the temperature inside the body, the devices close autonomously and clamp onto the colonic wall. The closing action causes the tiny, six-pointed devices to dig into the mucosa and remain attached to the colon, where they are retained and release their medicine payloads gradually into the body. Eventually, the theragrippers lose their hold on the tissue and are cleared from the intestine via normal gastrointestinal muscular function.
Gracias notes advances in the field of biomedical engineering in recent years.
“We have seen the introduction of dynamic, microfabricated smart devices that can be controlled by electrical or chemical signals,” he says. “But these grippers are so small that batteries, antennas and other components will not fit on them.”
Theragrippers, says Gracias, don’t rely on electricity, wireless signals or external controls. “Instead, they operate like small, compressed springs with a temperature-triggered coating on the devices that releases the stored energy autonomously at body temperature.”
The Johns Hopkins researchers fabricated the devices with about 6,000 theragrippers per 3-inch silicon wafer. In their animal experiments, they loaded a pain-relieving drug onto the grippers. The researchers’ studies found that the animals into which theragrippers were administered had higher concentrates of the pain reliever in their bloodstreams than did the control group. The drug stayed in the test subjects’ systems for nearly 12 hours versus two hours in the control group.
Context: Brain disorders remain the world’s leading cause of disability, and account for more hospitalizations and prolonged care than almost all other diseases combined. The majority of drugs, proteins and peptides do not readily permeate into brain due to the presence of the blood-brain barrier (BBB), thus impeding treatment of these conditions.
Objective: Attention has turned to developing novel and effective delivery systems to provide good bioavailability in the brain.
Methods: Intranasal administration is a non-invasive method of drug delivery that may bypass the BBB, allowing therapeutic substances direct access to the brain. However, intranasal administration produces quite low drug concentrations in the brain due limited nasal mucosal permeability and the harsh nasal cavity environment. Pre-clinical studies using encapsulation of drugs in nanoparticulate systems improved the nose to brain targeting and bioavailability in brain. However, the toxic effects of nanoparticles on brain function are unknown.
Result and conclusion: This review highlights the understanding of several brain diseases and the important pathophysiological mechanisms involved. The review discusses the role of nanotherapeutics in treating brain disorders via nose to brain delivery, the mechanisms of drug absorption across nasal mucosa to the brain, strategies to overcome the blood brain barrier, nanoformulation strategies for enhanced brain targeting via nasal route and neurotoxicity issues of nanoparticles.
Epub 2013 Oct 16.
NANOEMULSION-BASED INTRANASAL DRUG DELIVERY SYSTEM OF SAQUINAVIR MESYLATE FOR BRAIN TARGETING
The central nervous system (CNS) is an immunological privileged sanctuary site-providing reservoir for HIV-1 virus. Current anti-HIV drugs, although effective in reducing plasma viral levels, cannot eradicate the virus completely from the body. The low permeability of anti-HIV drugs across the blood-brain barrier (BBB) leads to insufficient delivery. Therefore, developing a novel approaches enhancing the CNS delivery of anti-HIV drugs are required for the treatment of neuro-AIDS. The aim of this study was to develop intranasal nanoemulsion (NE) for enhanced bioavailability and CNS targeting of saquinavir mesylate (SQVM). SQVM is a protease inhibitor which is a poorly soluble drug widely used as antiretroviral drug, with oral bioavailability is about 4%. The spontaneous emulsification method was used to prepare drug-loaded o/w nanoemulsion, which was characterized by droplet size, zeta potential, pH, drug content. Moreover, ex-vivo permeation studies were performed using sheep nasal mucosa. The optimized NE showed a significant increase in drug permeation rate compared to the plain drug suspension (PDS). Cilia toxicity study on sheep nasal mucosa showed no significant adverse effect of SQVM-loaded NE. Results of in vivo biodistribution studies show higher drug concentration in brain after intranasal administration of NE than intravenous delivered PDS. The higher percentage of drug targeting efficiency (% DTE) and nose-to-brain drug direct transport percentage (% DTP) for optimized NE indicated effective CNS targeting of SQVM via intranasal route. Gamma scintigraphy imaging of the rat brain conclusively demonstrated transport of drug in the CNS at larger extent after intranasal administration as NE.
Over the past few years, nasal drug delivery has attracted more and more attentions, and been recognized as the most promising alternative route for the systemic medication of drugs limited to intravenous administration. Many experiments in animal models have shown that nanoscale carriers have the ability to enhance the nasal delivery of peptide/protein drugs and vaccines compared to the conventional drug solution formulations. However, the rapid mucociliary clearance of the drug-loaded nanoparticles can cause a reduction in bioavailability percentage after intranasal administration. Thus, research efforts have considerably been directed towards the development of hydrogel nanosystems which have mucoadhesive properties in order to maximize the residence time, and hence increase the period of contact with the nasal mucosa and enhance the drug absorption. It is most certain that the high viscosity of hydrogel-based nanosystems can efficiently offer this mucoadhesive property. This update review discusses the possible benefits of using hydrogel polymer-based nanoparticles and hydrogel nanocomposites for drug/vaccine delivery through the intranasal administration.
Nanoparticles for nasal vaccination. Csaba N, Garcia-Fuentes M, Alonso MJ.Csaba N, et al.Adv Drug Deliv Rev. 2009 Feb 27;61(2):140-57. doi: 10.1016/j.addr.2008.09.005. Epub 2008 Dec 13.Adv Drug Deliv Rev. 2009.PMID: 19121350 Review.